Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$7.18bn	123.02	n/a
CU6Clarity Pharmaceuticals	AU$2.11bn	n/a	n/a
MSBMesoblast	AU$1.67bn	n/a	n/a
OPTOpthea	AU$993.23m	n/a	n/a
PYCPYC Therapeutics	AU$944.36m	n/a	n/a
IMMImmutep	AU$439.83m	n/a	n/a
IMUImugene	AU$358.70m	n/a	n/a
RACRace Oncology	AU$253.75m	n/a	n/a
DXBDimerix	AU$250.34m	n/a	n/a
LTPLtr Pharma	AU$222.38m	n/a	n/a
ALAArovella Therapeutics	AU$189.10m	n/a	n/a
CGSCogstate	AU$157.12m	19.6	n/a
PEBPacific Edge	NZ$120.88m	n/a	n/a
PIQProteomics International Laboratories	AU$102.10m	n/a	n/a
AGNArgenica Therapeutics	AU$95.25m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$78.83m	n/a	n/a
PERPercheron Therapeutics	AU$77.53m	n/a	n/a
ACWActinogen Medical	AU$73.45m	n/a	n/a
ADOAnteotech	AU$71.58m	n/a	n/a
NTINeurotech International	AU$51.89m	n/a	n/a